Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BioNTech Stock Tumbled on Tuesday

TheMotleyFool

0 0

For the second straight day, the share price of otherwise popular coronavirus stock BioNTech (NASDAQ: BNTX) fell on Tuesday. Despite there being no direct catalysts for such a drop, the shares of the German company ended the day nearly 3.5% lower.

BioNTech is, it nearly goes without saying by now, the co-developer of the Comirnaty coronavirus vaccine with pharmacuetical sector powerhouse Pfizer (NYSE: PFE). The jab is the only one fully approved for use in the U.S.; vaccines from Moderna and Johnson & Johnson's Janssen currently hold only Emergency Use Authorization (EUA).

Image source: Getty Images.

Source Fool.com

Like: 0

BNTX

Share